Rehabilitation Interventions in Head and Neck Cancer

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
CHENG, Jessica T.
EMOS, Marc Ramos
CAPOZZI, Lauren
WOODROW, Lindsey E.
GUTIERREZ, Carolina
NGO-HUANG, An
KRAUSE, Kate J.
PARKE, Sara C.
LANGELIER, David Michael
Citação
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, v.103, n.3S, suppl.1, p.S62-S71, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: The aim of the study is to identify and appraise current evidence for rehabilitation interventions in head and neck cancer. Design: A previously published scoping review spanning 1990 through April 2017 was updated through January 11, 2023 and narrowed to include only interventional studies (Arch Phys Med Rehabil. 2019;100(12):2381-2388). Included studies had a majority head and neck cancer population and rehabilitation-specific interventions. Pairs of authors extracted data and evaluated study quality using the PEDro tool. Results were organized by intervention type. Results: Of 1338 unique citations, 83 studies with 87 citations met inclusion criteria. The median study sample size was 49 (range = 9-399). The most common interventions focused on swallow (16 studies), jaw (11), or both (6), followed by whole-body exercise (14) and voice (10). Most interventions took place in the outpatient setting (77) and were restorative in intent (65 articles). The overall study quality was fair (median PEDro score 5, range 0-8); none were of excellent quality (PEDro >9). Conclusions: Most head and neck cancer rehabilitation interventions have focused on restorative swallow and jaw exercises and whole-body exercise to address dysphagia, trismus, and deconditioning. More high-quality evidence for head and neck cancer rehabilitation interventions that address a wider range of impairments and activity and social participation limitations during various cancer care phases is urgently needed to reduce head and neck cancer-associated morbidity.
Palavras-chave
Head and Neck Neoplasms, Rehabilitation, Trismus, Deglutition Disorders
URI
https://observatorio.fm.usp.br/handle/OPI/59096
Referências
  1. Aghili M, 2007, EUR J ONCOL NURS, V11, P179, DOI 10.1016/j.ejon.2006.03.005
  2. Ahlberg A, 2011, ACTA OTO-LARYNGOL, V131, P552, DOI 10.3109/00016489.2010.532157
  3. Angadi V., 2020, J Voice, V34, p962.
  4. [Anonymous], 2020, J PHYSIOTHER, V66, P59, DOI 10.1016/j.jphys.2019.08.005
  5. Atar S, 2023, PHYSIOTHER THEOR PR, V39, P1832, DOI 10.1080/09593985.2022.2056862
  6. Badr H, 2019, CANCER-AM CANCER SOC, V125, P1176, DOI 10.1002/cncr.31906
  7. Balbinot J, 2022, BRAZ J OTORHINOLAR, V88, P491, DOI 10.1016/j.bjorl.2020.10.005
  8. Bergström L, 2017, SUPPORT CARE CANCER, V25, P2683, DOI 10.1007/s00520-017-3676-x
  9. Borras JM, 2015, RADIOTHER ONCOL, V116, P45, DOI 10.1016/j.radonc.2015.04.021
  10. Bressan V, 2017, SUPPORT CARE CANCER, V25, P1699, DOI 10.1007/s00520-017-3618-7
  11. BUCHBINDER D, 1993, J ORAL MAXIL SURG, V51, P863, DOI 10.1016/S0278-2391(10)80104-1
  12. Campbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116
  13. Capozzi LC, 2016, CANCER-AM CANCER SOC, V122, P1185, DOI 10.1002/cncr.29863
  14. Carnaby-Mann G, 2012, INT J RADIAT ONCOL, V83, P210, DOI 10.1016/j.ijrobp.2011.06.1954
  15. Chen YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237133
  16. de Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1
  17. Denk DM, 1997, ORL J OTO-RHINO-LARY, V59, P100, DOI 10.1159/000276918
  18. DIETZ JH, 1969, MED CLIN N AM, V53, P607
  19. Do JH, 2018, ORAL ONCOL, V86, P100, DOI 10.1016/j.oraloncology.2018.06.019
  20. Du E, 2019, LARYNGOSCOPE, V129, P2506, DOI 10.1002/lary.27807
  21. Fong SSM, 2014, J CANCER SURVIV, V8, P618, DOI 10.1007/s11764-014-0372-4
  22. Fong SSM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/495274
  23. Garcia MK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16910
  24. Gkaintatzi E, 2022, CURR ONCOL, V29, P9305, DOI 10.3390/curroncol29120729
  25. Gormley M, 2022, BRIT DENT J, V233, P780, DOI 10.1038/s41415-022-5166-x
  26. Grandi Gisela, 2007, Med Oral Patol Oral Cir Bucal, V12, pE105
  27. Grote M, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1157-0
  28. Hajdú SF, 2021, DYSPHAGIA, DOI 10.1007/s00455-021-10320-5
  29. Hammerlid E, 1999, OTOLARYNG HEAD NECK, V120, P507
  30. Hogdal N, 2015, ACTA ONCOL, V54, P80, DOI 10.3109/0284186X.2014.954677
  31. Holm LV, 2012, SUPPORT CARE CANCER, V20, P2913, DOI 10.1007/s00520-012-1420-0
  32. Hsiang CC, 2019, ENT-EAR NOSE THROAT, V98, pE73, DOI 10.1177/0145561319839822
  33. Kangas M, 2013, PSYCHO-ONCOLOGY, V22, P1665, DOI 10.1002/pon.3208
  34. Karlsson T, 2022, ACTA ONCOL, V61, P349, DOI 10.1080/0284186X.2021.1995891
  35. Karlsson T, 2017, LOGOP PHONIATR VOCO, V42, P167, DOI 10.1080/14015439.2016.1250943
  36. Kotz T, 2012, ARCH OTOLARYNGOL, V138, P376, DOI 10.1001/archoto.2012.187
  37. Krisciunas GP, 2017, DYSPHAGIA, V32, P327, DOI 10.1007/s00455-016-9760-4
  38. Kwon DI, 2022, J LARYNGOL OTOL, V136, P433, DOI 10.1017/S0022215121003212
  39. Langmore SE, 2016, HEAD NECK-J SCI SPEC, V38, pE1221, DOI 10.1002/hed.24197
  40. Lauchlan DT, 2011, EUR J CANCER CARE, V20, P113, DOI 10.1111/j.1365-2354.2009.01149.x
  41. Law T, 2017, LARYNGOSCOPE, V127, P1119, DOI 10.1002/lary.26243
  42. Lazarus CL, 2014, INT J ORAL MAX SURG, V43, P523, DOI 10.1016/j.ijom.2013.10.023
  43. Lee JE, 2019, CANCER NURS, V42, P218, DOI 10.1097/NCC.0000000000000594
  44. Lee R, 2018, BRIT J ORAL MAX SURG, V56, P283, DOI 10.1016/j.bjoms.2018.02.012
  45. Li YH, 2019, CLIN ORAL INVEST, V23, P469, DOI 10.1007/s00784-018-2456-4
  46. Lin KY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031291
  47. Lin PH, 2011, SUPPORT CARE CANCER, V19, P91, DOI 10.1007/s00520-009-0792-2
  48. Lonbro S, 2013, RADIOTHER ONCOL, V108, P314, DOI 10.1016/j.radonc.2013.07.002
  49. Lonbro S, 2013, ACTA ONCOL, V52, P310, DOI 10.3109/0284186X.2012.741325
  50. Long YB, 2013, DISABIL REHABIL, V35, P450, DOI 10.3109/09638288.2012.697250
  51. Longobardi Y, 2020, EUR ARCH OTO-RHINO-L, V277, P2095, DOI 10.1007/s00405-020-05918-8
  52. Longobardi Y, 2019, SUPPORT CARE CANCER, V27, P3537, DOI 10.1007/s00520-019-4647-1
  53. Loorents V, 2014, ACTA ONCOL, V53, P530, DOI 10.3109/0284186X.2014.892211
  54. Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841
  55. Manier KK, 2018, NEURO-ONCOL PRACT, V5, P204, DOI 10.1093/nop/npy018
  56. Mashhour Karim, 2018, Asian Pac J Cancer Prev, V19, P797
  57. McEwen S, 2016, SUPPORT CARE CANCER, V24, P1449, DOI 10.1007/s00520-015-3021-1
  58. McGarvey AC, 2015, HEAD NECK-J SCI SPEC, V37, P1022, DOI 10.1002/hed.23712
  59. McLaughlin TM, 2020, LARYNGOSCOPE INVEST, V5, P879, DOI 10.1002/lio2.455
  60. McNeely ML, 2008, CANCER, V113, P214, DOI 10.1002/cncr.23536
  61. McNeely ML, 2015, PHYSIOTHER CAN, V67, P85, DOI 10.3138/ptc.2014-13O
  62. McNeely ML, 2004, HEAD NECK-J SCI SPEC, V26, P518, DOI 10.1002/hed.20010
  63. Medicine USNLo, 2021, Glossary of common site terms
  64. Messing BP, 2017, DYSPHAGIA, V32, P487, DOI 10.1007/s00455-017-9790-6
  65. Michael CM, 2021, CANCER MED-US, V10, P4195, DOI 10.1002/cam4.4021
  66. Millgård M, 2020, J VOICE, V34, DOI 10.1016/j.jvoice.2018.09.011
  67. Mortensen HR, 2015, DYSPHAGIA, V30, P304, DOI 10.1007/s00455-015-9600-y
  68. National Comprehensive Cancer Network, HEAD NECK CANC VERS
  69. Osazuwa-Peters N, 2018, CANCER-AM CANCER SOC, V124, P4072, DOI 10.1002/cncr.31675
  70. Ozdemir K, 2021, LARYNGOSCOPE, V131, pE1550, DOI 10.1002/lary.29205
  71. Paim ÉD, 2019, J ORAL REHABIL, V46, P1142, DOI 10.1111/joor.12851
  72. Parke SC, 2022, CURR ONCOL REP, V24, P517, DOI 10.1007/s11912-022-01227-x
  73. Parke SC, 2019, ARCH PHYS MED REHAB, V100, P2381, DOI 10.1016/j.apmr.2019.03.022
  74. Pauli N, 2015, HEAD NECK-J SCI SPEC, V37, P1738, DOI 10.1002/hed.23818
  75. Pergolotti M, 2015, J GERIATR ONCOL, V6, P194, DOI 10.1016/j.jgo.2015.01.004
  76. Pfister DG, 2010, J CLIN ONCOL, V28, P2565, DOI 10.1200/JCO.2009.26.9860
  77. Qin F, 2022, ACTA MEDICA MEDITERR, V38, P971, DOI 10.19193/0393-6384_2022_2_149
  78. Qualizza M, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.12939
  79. Ridner SH, 2021, SUPPORT CARE CANCER, V29, P795, DOI 10.1007/s00520-020-05540-8
  80. Ringash J, 2018, SEMIN RADIAT ONCOL, V28, P64, DOI 10.1016/j.semradonc.2017.08.008
  81. Rodriguez AM, 2019, DISABIL REHABIL, V41, P2093, DOI 10.1080/09638288.2018.1459880
  82. Rogers LQ, 2013, HEAD NECK-J SCI SPEC, V35, P1178, DOI 10.1002/hed.23118
  83. Ryu JS, 2009, ORAL ONCOL, V45, P665, DOI 10.1016/j.oraloncology.2008.10.005
  84. Sahin M, 2016, DIS ESOPHAGUS, V29, P41, DOI 10.1111/dote.12297
  85. Samuel SR, 2013, INDIAN J MED RES, V137, P515
  86. Samuel SR, 2019, SUPPORT CARE CANCER, V27, P3913, DOI 10.1007/s00520-019-04750-z
  87. Sandler ML, 2019, HEAD NECK-J SCI SPEC, V41, P3806, DOI 10.1002/hed.25908
  88. Semple CJ, 2009, SUPPORT CARE CANCER, V17, P379, DOI 10.1007/s00520-008-0480-7
  89. Shimada Y, 2007, ACTA OTO-LARYNGOL, V127, P491, DOI 10.1080/00016480600895151
  90. Silver JK, 2013, CA-CANCER J CLIN, V63, P295, DOI 10.3322/caac.21186
  91. Slovarp LJ., 2015, Contrasting Two Prophylactic Dysphagia Interventions for Patients with Head and Neck Cancer Treated with Radiotherpy with or without Adjunctive Chemotherapy
  92. Su TL, 2017, ORAL ONCOL, V74, P130, DOI 10.1016/j.oraloncology.2017.10.002
  93. Tang Y, 2011, STRAHLENTHER ONKOL, V187, P39, DOI 10.1007/s00066-010-2151-0
  94. Taylor JC, 2004, ARCH OTOLARYNGOL, V130, P764, DOI 10.1001/archotol.130.6.764
  95. Tsai KY, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000030910
  96. Tuomi L, 2022, HEAD NECK-J SCI SPEC, V44, P862, DOI 10.1002/hed.26982
  97. Tuomi L, 2014, INT J RADIAT ONCOL, V89, P964, DOI 10.1016/j.ijrobp.2014.04.030
  98. Tuomi L, 2014, J VOICE, V28, P62, DOI 10.1016/j.jvoice.2013.02.008
  99. Vakharia KT, 2007, OTOLARYNG HEAD NECK, V136, P405, DOI 10.1016/j.otohns.2006.10.018
  100. Van den Hoogen FJA, 1998, CLIN OTOLARYNGOL, V23, P425, DOI 10.1046/j.1365-2273.1998.00164.x
  101. van der Geer SJ, 2020, SUPPORT CARE CANCER, V28, P9, DOI 10.1007/s00520-019-05075-7
  102. van der Molen L, 2014, EUR ARCH OTO-RHINO-L, V271, P1257, DOI 10.1007/s00405-013-2640-8
  103. van der Molen L, 2011, DYSPHAGIA, V26, P155, DOI 10.1007/s00455-010-9288-y
  104. van Gogh CDL, 2006, CANCER-AM CANCER SOC, V106, P95, DOI 10.1002/cncr.21578
  105. van Rooijen S, 2019, BMC CANCER, V19, DOI 10.1186/s12885-018-5232-6
  106. Wen LY, 2023, SUPPORT CARE CANCER, V31, DOI 10.1007/s00520-022-07548-8
  107. WHO, 2023, International classification of functioning, disability, and health (ICF)
  108. Wong Raimond K, 2010, J Soc Integr Oncol, V8, P35
  109. Wu PX, 2018, EUR ARCH OTO-RHINO-L, V275, P795, DOI 10.1007/s00405-018-4875-x
  110. Xiao CH, 2013, ORAL ONCOL, V49, P360, DOI 10.1016/j.oraloncology.2012.10.004
  111. Yen CJ, 2019, SUPPORT CARE CANCER, V27, P4687, DOI 10.1007/s00520-019-04786-1
  112. Zatarain LA, 2018, INTEGR CANCER THER, V17, P960, DOI 10.1177/1534735418784363
  113. Zhang J, 2022, ORAL ONCOL, V134, DOI 10.1016/j.oraloncology.2022.106097
  114. Zhao SG, 2016, HEAD NECK-J SCI SPEC, V38, pE1086, DOI 10.1002/hed.24162
  115. Zimmermann T, 2005, BIOL TRACE ELEM RES, V106, P193, DOI 10.1385/BTER:106:3:193

Coleções
Artigos e Materiais de Revistas Científicas - FM/Outros